This may be due to genetic factors, such as the PNPLA3 mutation, which is linked to an increased risk of hepatic steatosis and NASH, particularly in Hispanics [20,21]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatohepatitis.